On December 12, 2018, with strong bipartisan support, Congress quietly passed the Agricultural Improvements Act of 2018 (H.R. 2), affectionately known as the Farm Bill. The President’s signature is expected.
Buried within the Farm Bill are explicit protections for hemp production from the Cannabis sativa L. plant, including all parts of the plant as well as any “and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a [THC] concentration of not more than 0.3 percent on a dry weight basis.” And, this is huge, the final sentence of the 529 page Farm Bill removed THC found in hemp from the Controlled Substances Act entirely. This means that for the first time in over 45 years, THC from hemp is no longer deemed to have “no currently accepted medical use.” To be clear – this is not legalization of marijuana or its derivatives (see our prior post for differences between THC and CBD).
Nonetheless, the impacts on the medical and recreational/adult use markets are substantial. While hemp grown from the sativa plant tends to be very low in THC, it is a viable source for CBD extracts. CBD is promising for its medicinal properties without producing the euphoric “highs” resulting from THC. The question remains: once hemp and CBD derivatives are legal, can medical marijuana (or recreational use) be far behind?
While we have been optimistic in this field, now is the time for businesses that have been exploring the field to finally plant the seeds of change. Though full legalization of medical marijuana is not yet a reality, CBD lawfully sourced from hemp is a means to begin growing a business that can by hybridized to include THC products when it is also made lawful (albeit still highly regulated). Speak with legal counsel to establish business essentials.
Welcome to the Cannabis Business Legal News blog where attorneys from Amundsen Davis blog about all things cannabis business and legal news related.
- Historic Cannabis Rescheduling on the Horizon? It's Up to the DEA Now
- FDA Issues First Ever Guidance for Research of Psychedelics
- Movement on the SAFE Banking Act? The Senate is Talking the Talk, but Not Ready to Walk the Walk
- The Federal Government & CBD – What the FDA is Happening?
- Illinois Lawmaker Introduces Legislation to Legalize Psychedelic Therapy Programs
- Illinois Set to Roll out New Cannabis Retail License Applications and Lottery in Early 2023
- Could a Small Town in Pennsylvania Force Congress to Deschedule Cannabis?
- No April Fool’s Joke: The MORE Act was Just Passed by the House
- Significant Increase in Production of Cannabis and Psychedelics for Research Proposed by the DEA for 2022 – What You Need to Know Now
- Protecting Your Cannabis Business from the Trappings of the Telephone Consumer Protection Act
- August 2023
- May 2023
- January 2023
- November 2022
- April 2022
- October 2021
- August 2021
- July 2021
- May 2021
- December 2020
- April 2020
- December 2019
- November 2019
- August 2019
- June 2019
- May 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- June 2018
- May 2018
- July 2016